ASKA Pharmaceutical Co., Ltd. and KinoPharma, Inc. Enter into Option Agreement for Treatment of Cervical Dysplasia
Cervical dysplasia is a preliminary stage of cervical cancer, and its causes are predominantly due to persistent infections of human papillomaviruses (HPV) in the cervix.
- Cervical dysplasia is a preliminary stage of cervical cancer, and its causes are predominantly due to persistent infections of human papillomaviruses (HPV) in the cervix.
- Excision surgery is the first choice for high-grade cervical dysplasia, but it has been reported that the surgery increases the risk of premature delivery.
- At present, there is no medication for treating HPV in case of the low- and moderate-grade cervical dysplasia.
- Established in April 2005, KinoPharma is a pharmaceutical company engaged in research and development of drugs in collaboration with Kyoto University.